Workflow
Protalix BioTherapeutics(PLX)
icon
搜索文档
Protalix BioTherapeutics(PLX) - 2020 Q1 - Earnings Call Transcript
2020-06-01 23:17
Protalix Bio Therapeutics (NYSE:PLX) Q1 2020 Earnings Conference Call June 1, 2020 8:30 AM ET Company Participants Dror Bashan - President, Chief Executive Officer Eyal Rubin - Senior Vice President, Chief Financial Officer Chuck Padala - Investor Relations Conference Call Participants Boobalan Pachaiyappan - HC Wainwright Philippa Gardner - Jefferies Walter Goering - private investor Operator Greetings and welcome to the Protalix Bio Therapeutics first quarter 2020 earnings conference call. At this time, a ...
Protalix BioTherapeutics(PLX) - 2019 Q4 - Earnings Call Transcript
2020-03-12 23:49
Protalix BioTherapeutics, Inc. (NYSE:PLX) Q4 2019 Earnings Conference Call March 12, 2020 8:30 AM ET Company Participants Monique Kosse - IR, LifeSci Advisors Dror Bashan - President & CEO Eyal Rubin - CFO Conference Call Participants Boobalan Pachaiyappan - H.C. Wainwright Peter Welford - Jefferies Operator Greetings and welcome to the Protalix Biopharmaceuticals reports Fourth Quarter and Full-Year 2019 Financial and Business Results Conference Call. At this time, all participants are in a listen-only mod ...
Protalix BioTherapeutics(PLX) - 2019 Q4 - Earnings Call Presentation
2020-03-12 22:05
Protalix BioTherapeutics, Inc. CORPORATE UPDATE | FEBRUARY 2020 Note Regarding Forward-Looking Statements This presentation (the "Presentation") contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements, including, among others, statements regarding expectations as to regulatory approvals, market opportunity for, and potential sales of, the Company's product and product candid ...
Protalix Biotherapeutics (PLX) Investor Presentation - Slideshow
2020-02-20 03:02
Protalix BioTherapeutics, Inc. CORPORATE UPDATE | FEBRUARY 2020 Note Regarding Forward-Looking Statements This presentation (the "Presentation") contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements, including, among others, statements regarding expectations as to regulatory approvals, market opportunity for, and potential sales of, the Company's product and product candid ...
Protalix BioTherapeutics(PLX) - 2019 Q3 - Earnings Call Transcript
2019-11-08 03:32
Protalix BioTherapeutics, Inc. (NYSE:PLX) Q3 2019 Earnings Conference Call November 7, 2019 8:30 AM ET Company Participants Dror Bashan - President and Chief Executive Officer Eyal Rubin - Senior Vice President and Chief Financial Officer Conference Call Participants Operator Good day. And welcome to the Protalix Biotherapeutics Third Quarter 2019 Earnings Call. Today's call is being recorded. At this time, I'd like to turn the conference over to [Mani Kasi] of LifeSci Advisors. Please go ahead. Unidentifie ...
Protalix BioTherapeutics(PLX) - 2019 Q2 - Earnings Call Transcript
2019-08-09 01:34
Protalix Biotherapeutics, Inc. (NYSE:PLX) Q2 2019 Earnings Conference Call August 8, 2019 8:30 AM ET Company Participants Dror Bashan - President & CEO Conference Call Participants Edward Marks - H.C. Wainwright & Co. Peter Welford - Jefferies Operator Good morning ladies and gentlemen and welcome to the Protalix Second Quarter 2019 Financial Results and Corporate Conference Call. At this time all participants are in a listen-only mode. Later we will conduct a question and answer session and instructions wi ...
Protalix BioTherapeutics(PLX) - 2019 Q1 - Earnings Call Transcript
2019-05-07 00:28
Protalix Biotherapeutics, Inc. (NYSE:PLX) Q1 2019 Earnings Conference Call May 6, 2019 8:30 AM ET Company Participants Yossi Maimon - CFO, VP, Treasurer & Secretary Moshe Manor - CEO, President & Director Conference Call Participants Edward Marks - H.C. Wainwright & Co. Peter Welford - Jefferies Operator Good day, ladies and gentlemen, and welcome to the Protalix First Quarter 2019 Financial Results and Corporate Conference Call. [Operator Instructions]. As a reminder, this call will be recorded. I would no ...
Protalix BioTherapeutics(PLX) - 2018 Q4 - Earnings Call Transcript
2019-03-19 00:11
Protalix BioTherapeutics, Inc. (NYSE:PLX) Q4 2018 Earnings Conference Call March 18, 2019 8:30 AM ET Company Participants Yossi Maimon - CFO Moshe Manor - CEO Conference Call Participants Ram Selvaraju - H.C. Wainwright Operator Good day, ladies and gentlemen, and welcome to the Protalix Full Year 2018 Financial Results and Corporate Update. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to introduce your host for todayÂ's conference, Yossi Maimon, Chief Fina ...